A detailed history of Foster Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Foster Group, Inc. holds 7,050 shares of ABT stock, worth $830,208. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,050
Previous 6,792 3.8%
Holding current value
$830,208
Previous $705,000 13.9%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$100.07 - $118.13 $25,818 - $30,477
258 Added 3.8%
7,050 $803,000
Q2 2024

Jul 30, 2024

SELL
$100.73 - $112.44 $24,678 - $27,547
-245 Reduced 3.48%
6,792 $705,000
Q1 2024

Apr 09, 2024

BUY
$109.52 - $120.96 $21,684 - $23,950
198 Added 2.9%
7,037 $799,000
Q3 2023

Oct 27, 2023

BUY
$95.53 - $114.62 $20,061 - $24,070
210 Added 3.17%
6,839 $662,000
Q2 2023

Jul 10, 2023

BUY
$100.78 - $112.29 $25,799 - $28,746
256 Added 4.02%
6,629 $722,000
Q1 2023

Apr 06, 2023

BUY
$96.86 - $114.01 $31,770 - $37,395
328 Added 5.43%
6,373 $645,000
Q4 2022

Jan 23, 2023

SELL
$95.06 - $111.52 $38,119 - $44,719
-401 Reduced 6.22%
6,045 $0
Q3 2022

Oct 13, 2022

BUY
$96.76 - $112.03 $42,671 - $49,405
441 Added 7.34%
6,446 $624,000
Q2 2022

Jul 25, 2022

BUY
$102.07 - $123.37 $25,109 - $30,349
246 Added 4.27%
6,005 $652,000
Q1 2022

Apr 22, 2022

SELL
$114.02 - $139.04 $1,368 - $1,668
-12 Reduced 0.21%
5,759 $682,000
Q4 2021

Feb 02, 2022

BUY
$115.53 - $141.46 $1,386 - $1,697
12 Added 0.21%
5,771 $812,000
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $34,998 - $38,718
-300 Reduced 4.95%
5,759 $680,000
Q2 2021

Aug 09, 2021

SELL
$105.79 - $124.53 $5,712 - $6,724
-54 Reduced 0.88%
6,059 $702,000
Q1 2021

Apr 20, 2021

SELL
$108.84 - $128.23 $52,896 - $62,319
-486 Reduced 7.36%
6,113 $733,000
Q4 2020

Jan 21, 2021

BUY
$105.0 - $114.42 $692,895 - $755,057
6,599 New
6,599 $711,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Foster Group, Inc. Portfolio

Follow Foster Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Foster Group, Inc. with notifications on news.